Appendix Table C80Comparative harms: combination oral selective antihistamine plus intranasal corticosteroid versus oral selective antihistamine

Author, YearTreatment GroupN/nSedationHeadacheBurningNosebleeds
Anolik, 2008Mometasone furoate 200 mcg/Loratadine 10 mg169/166MOD: 2MOD: 4MOD: 2MOD: 4
Loratadine 10 mg181/175MOD: 2MOD: 8MOD: 0MOD: 1
Benincasa, 1994aFluticasone propionate 200 mcg227/227SEV: 1.3SEV: 0.4SEV: 0.4
Fluticasone propionate 200 mcg/Cetirizine 10 mg227/227
Ratner, 1998Loratadine 10 mg150/150≤1b
Fluticasone propionate 200 mcg150/150
Loratadine 10 mg/Fluticasone propionate 200 mcg150/150

N/n = Number of patients randomized/number of patients analyzed.

Symptom severity is unspecified unless otherwise noted (MILD, MOD = moderate, or SEV = severe).

a

Number of reports.

b

Across all treatment groups. Adverse events are not otherwise broken down by group.

From: Appendix C, Evidence Tables

Cover of Treatments for Seasonal Allergic Rhinitis
Treatments for Seasonal Allergic Rhinitis [Internet].
Comparative Effectiveness Reviews, No. 120.
Glacy J, Putnam K, Godfrey S, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.